This Article Full Text Full Text (PDF) All Versions of this Article: 37/7/1720    most recent 01.STR.0000227004.08182.bfv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tanne, D. Articles by Behar, S. Search for Related Content PubMed PubMed Citation Articles by Tanne, D. Articles by Behar, S. Related Collections Risk Factors Acute Cerebral Infarction Chronic ischemic heart disease

(Stroke. 2006;37:1720.)
© 2006 American Heart Association, Inc.

Original Contributions

C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease

David Tanne, MD; Michal Benderly, PhD; Uri Goldbourt, PhD; Moti Haim, MD; Alexander Tenenbaum, MD, PhD; Enrique Z. Fisman, MD; Zipora Matas, PhD; Yehuda Adler, MD; Reuven Zimmlichman, MD Solomon Behar, MD

From the Stroke Center, Department of Neurology (D.T.), Neufeld Cardiac Research Institute (M.B., U.G., S.B.), and Cardiac Rehabilitation Institute (A.T., Y.A., E.Z.F.), Sheba Medical Center, Tel Hashomer; Cardiology Department, Rabin Medical Center, Petach Tikva (M.H.); Chemistry Laboratory, Wolsfon Medical Center, Holon (Z.M., R.Z.); and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (D.T., M.B., U.G., M.H., Z.M., R.Z., A.T., Y.A., E.Z.F., S.B.), Israel.

Correspondence to David Tanne, MD, Stroke Center, Department of Neurology and Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel. E-mail tanne{at}post.tau.ac.il

Background and Purpose— C-reactive protein (CRP) has emerged as an important predictor of cardiovascular disease, but there are few prospective data on its association with risk of ischemic stroke in patients at high risk.

Methods— We examined the association between CRP levels and subsequent risk of incident ischemic stroke among 2979 patients with stable coronary heart disease included in a controlled clinical trial (Bezafibrate Infarction Prevention) that assessed the efficacy of bezafibrate, a fibric acid derivative, versus placebo for secondary prevention. CRP was measured by a high-sensitivity assay in plasma samples collected before randomization and again at the second follow-up year of an overall mean follow-up of 6.2 years.

Results— Risk of ischemic stroke per 1000 person-years increased from 4.1% for baseline CRP in the lowest tertile (<2.3 mg/L; n=982) to 5.9% for levels at the middle tertile (2.3 to 5.4 mg/L; n=1013) and 10.5% for CRP levels at the upper tertile (>5.4 mg/L; n=984; P<0.001). With adjustment for potential confounders, baseline CRP levels in the top versus bottom tertile were associated with a 2.16-fold increased hazard (95% CI, 1.32 to 3.53) for ischemic stroke, and CRP levels measured after 2 years were associated with a hazard ratio of 2.43 (95% CI, 1.30 to 4.57). The risk of an incident ischemic stroke did not differ between the bezafibrate group compared with the placebo group regardless of baseline CRP levels.

Conclusions— These findings, based on a large prospective study, demonstrate the risk prediction for incident ischemic stroke conferred by CRP levels in patients at high risk.

Key Words: epidemiology • inflammation • risk factors • stroke

This article has been cited by other articles:

				W. Whiteley, W. L. Chong, A. Sengupta, and P. Sandercock Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review Stroke, May 1, 2009; 40(5): e380 - e389. [Abstract] [Full Text] [PDF]

				A. Hiukka, J. Westerbacka, E. S. Leinonen, H. Watanabe, O. Wiklund, L. M. Hulten, J. T. Salonen, T.-P. Tuomainen, H. Yki-Jarvinen, A. C. Keech, et al. Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2190 - 2197. [Abstract] [Full Text] [PDF]

				S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo Coffee and Tea Consumption and Risk of Stroke Subtypes in Male Smokers Stroke, June 1, 2008; 39(6): 1681 - 1687. [Abstract] [Full Text] [PDF]

				M. W. Lorenz, P. Karbstein, H. S. Markus, and M. Sitzer High-Sensitivity C-Reactive Protein Is Not Associated With Carotid Intima-Media Progression: The Carotid Atherosclerosis Progression Study Stroke, June 1, 2007; 38(6): 1774 - 1779. [Abstract] [Full Text] [PDF]